A Retrospective Evaluation of the Steroid-Sparing Effect of Oral Modified Ciclosporin for Treatment of Canine Pemphigus Foliaceus

The efficacy of ciclosporin as an adjuvant immunosuppressant administered with glucocorticoids (GCs) for induction of canine PF remission is unknown. This study is a retrospective review of medical records from 2015 to 2020 to evaluate the therapeutic outcomes of 11 PF dogs treated with oral modifie...

Full description

Bibliographic Details
Main Authors: Eric Chong, Michaela Austel, Frane Banovic
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Veterinary Sciences
Subjects:
Online Access:https://www.mdpi.com/2306-7381/9/4/153
_version_ 1797443293687054336
author Eric Chong
Michaela Austel
Frane Banovic
author_facet Eric Chong
Michaela Austel
Frane Banovic
author_sort Eric Chong
collection DOAJ
description The efficacy of ciclosporin as an adjuvant immunosuppressant administered with glucocorticoids (GCs) for induction of canine PF remission is unknown. This study is a retrospective review of medical records from 2015 to 2020 to evaluate the therapeutic outcomes of 11 PF dogs treated with oral modified ciclosporin and GCs. Concurrent GCs were given with ciclosporin to all PF dogs. Nine dogs (9/11) achieved complete remission (CR); five dogs received ciclosporin at a mean dose of 6.2 mg/kg/day; and four dogs received a combination of ciclosporin and ketoconazole at a mean dose of 3 mg/kg/day, respectively. Two dogs (2/11) showed only 25% or poor response, with the development of new PF lesions during treatment. The mean duration of ciclosporin therapy for nine dogs to achieve CR was 65 days (median 57 days, range 24–119 days). Slow tapering of oral GCs while continuing ciclosporin at the same dose and frequency in nine dogs with CR led to recurrence of PF lesions in four dogs, whereas, in five dogs, oral glucocorticoids were discontinued without a PF flare. Oral modified ciclosporin combined with GCs achieved CR in 9 out of 11 PF dogs during the induction phase in this study.
first_indexed 2024-03-09T12:53:53Z
format Article
id doaj.art-6bccb679dc5744a187097f36064f30bf
institution Directory Open Access Journal
issn 2306-7381
language English
last_indexed 2024-03-09T12:53:53Z
publishDate 2022-03-01
publisher MDPI AG
record_format Article
series Veterinary Sciences
spelling doaj.art-6bccb679dc5744a187097f36064f30bf2023-11-30T22:02:51ZengMDPI AGVeterinary Sciences2306-73812022-03-019415310.3390/vetsci9040153A Retrospective Evaluation of the Steroid-Sparing Effect of Oral Modified Ciclosporin for Treatment of Canine Pemphigus FoliaceusEric Chong0Michaela Austel1Frane Banovic2College of Veterinary Medicine, University of Georgia, Athens, GA 30602, USACollege of Veterinary Medicine, University of Georgia, Athens, GA 30602, USACollege of Veterinary Medicine, University of Georgia, Athens, GA 30602, USAThe efficacy of ciclosporin as an adjuvant immunosuppressant administered with glucocorticoids (GCs) for induction of canine PF remission is unknown. This study is a retrospective review of medical records from 2015 to 2020 to evaluate the therapeutic outcomes of 11 PF dogs treated with oral modified ciclosporin and GCs. Concurrent GCs were given with ciclosporin to all PF dogs. Nine dogs (9/11) achieved complete remission (CR); five dogs received ciclosporin at a mean dose of 6.2 mg/kg/day; and four dogs received a combination of ciclosporin and ketoconazole at a mean dose of 3 mg/kg/day, respectively. Two dogs (2/11) showed only 25% or poor response, with the development of new PF lesions during treatment. The mean duration of ciclosporin therapy for nine dogs to achieve CR was 65 days (median 57 days, range 24–119 days). Slow tapering of oral GCs while continuing ciclosporin at the same dose and frequency in nine dogs with CR led to recurrence of PF lesions in four dogs, whereas, in five dogs, oral glucocorticoids were discontinued without a PF flare. Oral modified ciclosporin combined with GCs achieved CR in 9 out of 11 PF dogs during the induction phase in this study.https://www.mdpi.com/2306-7381/9/4/153caninepemphigus foliaceusciclosporin
spellingShingle Eric Chong
Michaela Austel
Frane Banovic
A Retrospective Evaluation of the Steroid-Sparing Effect of Oral Modified Ciclosporin for Treatment of Canine Pemphigus Foliaceus
Veterinary Sciences
canine
pemphigus foliaceus
ciclosporin
title A Retrospective Evaluation of the Steroid-Sparing Effect of Oral Modified Ciclosporin for Treatment of Canine Pemphigus Foliaceus
title_full A Retrospective Evaluation of the Steroid-Sparing Effect of Oral Modified Ciclosporin for Treatment of Canine Pemphigus Foliaceus
title_fullStr A Retrospective Evaluation of the Steroid-Sparing Effect of Oral Modified Ciclosporin for Treatment of Canine Pemphigus Foliaceus
title_full_unstemmed A Retrospective Evaluation of the Steroid-Sparing Effect of Oral Modified Ciclosporin for Treatment of Canine Pemphigus Foliaceus
title_short A Retrospective Evaluation of the Steroid-Sparing Effect of Oral Modified Ciclosporin for Treatment of Canine Pemphigus Foliaceus
title_sort retrospective evaluation of the steroid sparing effect of oral modified ciclosporin for treatment of canine pemphigus foliaceus
topic canine
pemphigus foliaceus
ciclosporin
url https://www.mdpi.com/2306-7381/9/4/153
work_keys_str_mv AT ericchong aretrospectiveevaluationofthesteroidsparingeffectoforalmodifiedciclosporinfortreatmentofcaninepemphigusfoliaceus
AT michaelaaustel aretrospectiveevaluationofthesteroidsparingeffectoforalmodifiedciclosporinfortreatmentofcaninepemphigusfoliaceus
AT franebanovic aretrospectiveevaluationofthesteroidsparingeffectoforalmodifiedciclosporinfortreatmentofcaninepemphigusfoliaceus
AT ericchong retrospectiveevaluationofthesteroidsparingeffectoforalmodifiedciclosporinfortreatmentofcaninepemphigusfoliaceus
AT michaelaaustel retrospectiveevaluationofthesteroidsparingeffectoforalmodifiedciclosporinfortreatmentofcaninepemphigusfoliaceus
AT franebanovic retrospectiveevaluationofthesteroidsparingeffectoforalmodifiedciclosporinfortreatmentofcaninepemphigusfoliaceus